Cidara Therapeutics (CDTX): Highlights From Analyst Day - HC Wainwright

April 17, 2017 7:18 AM EDT Send to a Friend
H.C. Wainwright analyst, Ed Acre, reiterated his Buy rating on shares of Cidara Therapeutics (NASDAQ: CDTX) after attending Cidara's annual ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login